English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/203057
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Carboranylanilinoquinazoline EGFR-inhibitors: toward ‘lead-to-candidate’ stage in the drug-development pipeline

AuthorsCouto, Marcos; Alamón, Catalina; Sánchez, Carina; Dávila, Belén; Fernández, Marcelo; Lecot, Nicole; Cabral, Pablo; Teixidor, Francesc ; Viñas, Clara ; Cerecetto, Hugo
Issue DateSep-2019
Publisher version (URL)http://dx.doi.org/10.4155/fmc-2019-0060
URIhttp://hdl.handle.net/10261/203057
Appears in Collections:(ICMAB) Artículos
Files in This Item:
File Description SizeFormat 
Couto_FutMedChem_2019_postprint.pdf1,33 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.